High Point Advisor Group LLC Biogen Inc. Transaction History
High Point Advisor Group LLC
- $1.76 Billion
- Q2 2024
A detailed history of High Point Advisor Group LLC transactions in Biogen Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 1,899 shares of BIIB stock, worth $330,027. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,899
Previous 1,907
0.42%
Holding current value
$330,027
Previous $411,000
7.06%
% of portfolio
0.02%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.88 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.84 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.53 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$987 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...